MedPath

Florbenazine F-18

Generic Name
Florbenazine F-18
Drug Type
Small Molecule
Chemical Formula
C21H32FNO3
CAS Number
956903-29-0
Unique Ingredient Identifier
KM31LBX59H

Overview

Florbenazine F-18 is under investigation in clinical trial NCT01515384 (A Trial of 18F-AV-133 Positron Emission Tomography (PET)).

Background

Florbenazine F-18 is under investigation in clinical trial NCT01515384 (A Trial of 18F-AV-133 Positron Emission Tomography (PET)).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Phase 1
Completed
Posted: 2012/10/19
Sponsor:
Avid Radiopharmaceut...
ID:NCT01710371
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Phase 2
Completed
Posted: 2012/03/12
Sponsor:
Avid Radiopharmaceut...
ID:NCT01550484
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
Phase 1
Terminated
Posted: 2012/01/24
Sponsor:
Avid Radiopharmaceut...
ID:NCT01515384
A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Phase 1
Completed
Posted: 2012/01/04
Sponsor:
Avid Radiopharmaceut...
ID:NCT01503944

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy